{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:15:08Z","timestamp":1769883308320,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009411","name":"Universite Paris-Est Creteil Val de Marne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.diagmicrobio.2025.116753","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:10:02Z","timestamp":1740503402000},"page":"116753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Performance of the cobas 5800 System for Hepatitis B virus DNA and Hepatitis C virus RNA quantification"],"prefix":"10.1016","volume":"112","author":[{"given":"Erwan","family":"Vo-Quang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Rosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Garrigou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Ingiliz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6913-9017","authenticated-orcid":false,"given":"St\u00e9phane","family":"Chevaliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0001","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0003","series-title":"Combating hepatitis B and C to reach elimination by 2030","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating Hepatitis C Virus infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0005","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"Clinical Practice Guidelines Panel C, representative EGB, Panel m. EASL recommendations on treatment of hepatitis C: final update of the series(\u2606)","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0008","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0010","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.01300-08","article-title":"Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification","volume":"47","author":"Chevaliez","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104531","article-title":"Multicenter clinical evaluation of alinity m HCV assay performance","volume":"129","author":"Chevaliez","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0012","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1756283X17722745","article-title":"Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study","volume":"10","author":"Maasoumy","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104331","article-title":"Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples","volume":"126","author":"Mouna","year":"2020","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116753_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030573","article-title":"Diagnosis and monitoring of Hepatitis B virus infection using the Cobas HBV test for use on the Cobas 4800 system","volume":"9","author":"Ortonne","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14737159.2020.1820327","article-title":"Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping","volume":"20","author":"Yip","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0016","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1053\/j.gastro.2006.07.022","article-title":"Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin","volume":"131","author":"Bronowicki","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0017","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2012.11.039","article-title":"Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside\/nucleotide analogue therapy: finite treatment duration unlikely","volume":"58","author":"Chevaliez","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0018","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1038\/s41598-018-22614-0","article-title":"A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination","volume":"8","author":"Rodriguez","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0019","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0020","doi-asserted-by":"crossref","first-page":"142-56 e2","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of Hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116753_bib0021","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3343\/alm.2023.0306","article-title":"Performance evaluation of the Roche Cobas 5800 HBV and HCV tests: comparison of the 200 and 500 muL protocols","volume":"44","author":"Jeong","year":"2024","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diagmicrobio.2025.116753_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03125-22","article-title":"Multisite performance evaluation of the cobas 5800 system and comparison to the cobas 6800\/8800 systems for quantitative measurement of HBV, HCV, and HIV-1 viral load","volume":"10","author":"Tschape","year":"2022","journal-title":"Microbiol Spectr"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:25:47Z","timestamp":1744237547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0732889325000768"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116753","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the cobas 5800 System for Hepatitis B virus DNA and Hepatitis C virus RNA quantification","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116753"}}